在中风后的中,发作的结果和抗药物的使用:一项回顾性队列研究
Ahmed Khadija1, Jacques Theitler2, Revital Gandelman-Marton2
1Neurology Department, Shamir-Assaf Harofeh Medical Center, Tel Aviv University, Zerifin, Israel.
Epilepsy research
|June 20, 2025
概括
脑卒中后 (PSE) 患者的发作结果可能不如预期那么有利. 许多人使用旧的抗发作药物 (ASM) 进行治疗,这些药物可能会增加风险,需要新的治疗策略.
科学领域:
- 神经学 神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 临床医学 临床医学
背景情况:
- 脑卒中后 (PSE) 通常被认为是通过抗发作药物 (ASM) 得到良好控制的.
- 第一代ASM可以降低其他药物的疗效,并且与PSE的死亡率更高有关.
- 这强调了需要重新评估目前对PSE的治疗模式.
研究的目的:
- 为了评估患有中风后 (PSE) 患者的发作结果.
- 分析PSE患者使用抗发作药物 (ASM) 的模式.
- 为了比较PSE结果与没有先前中风的焦点 (FEWS).
主要方法:
- 对2012-2021年成人门诊临床记录的回顾性审查.
- 鉴定了39名PSE患者和382名FEWS患者.
- 对第一次和最后一次观察时的发作频率和ASM治疗的分析.
主要成果:
- 在最初的观察中,与少数人相比,患有PSE的患者每日或每月发作率较低,单次发作率较高.
- 较少的PSE患者经历了发作频率的改善,而在最后一次观察时,相比之下,只有少数患者.
- 在FEWS患者中观察到每日到每月发作的显著减少,但在PSE患者中没有显著减少.
结论:
- 在PSE中,控制可能不如以前想象的那么有利.
- 许多PSE患者接受第一代ASM治疗,这可能会增加血管风险.
- 进一步的研究至关重要,以开发改进的治疗策略,以更好地控制和PSE的自由.
相关概念视频
Epilepsy and Seizures: Overview
296
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
296
Seizures: Classification
612
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
612
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
461
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
461
Antiepileptic Drugs: Potassium Channel Activators
289
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
289
Antiepileptic Drugs: GABAergic Pathway Potentiators
681
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
681
Antiepileptic Drugs: Sodium Channel Blockers
950
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
950


